Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

This research has yet to be peer-reviewed. And unlike other prevention tools like oral pre-exposure prophylaxis (PrEP) and ...

The Lagos State Government has announced a plan to reduce malaria prevalence below 1% through the launch of the Pathway to Malaria Pre-Elimination & Digitization Program. According to the State, it’s ...

A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by making a drug that has been around since the 1970s last longer.

With malaria being one of the most significant causes of morbidity and mortality worldwide, prompt and effective treatment is essential to reduce the malaria burden. As there are several treatment ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

LONDON, Feb 21 (Reuters) - The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases including HIV and malaria in some of the world's ...

Malaria remains one of the greatest global health threats. In 2022, there were an estimated 247 million infections and over 600,000 deaths, mostly in sub-Saharan Africa.

The 2024 Africa Malaria Progress Report has revealed Africa recorded a 60 percent reduction in mortality since 2,000. The continent also saw a 38 percent decline in malaria incidence, preventing 1.8 ...

A Minnesota woman has died of malaria after traveling abroad, helping children in Uganda. Khristina Lund lived in Loretto and died earlier this month. "It's incredibly tough," said Kelly Froehle.

ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older in the United States (U.S.) It is sold under the brand name KODATEF in Australia, where it is ...